Biosante Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Biosante Pharmaceuticals by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $2.5M | 42k | 59.66 |
2024-06-30 | $2.7M | 42k | 63.68 |
2024-03-31 | $2.5M | 37k | 69.13 |
2023-12-31 | $2.1M | 38k | 55.14 |
2023-09-30 | $2.3M | 40k | 58.06 |
2023-06-30 | $1.9M | 35k | 53.83 |
2023-03-31 | $1.3M | 34k | 39.72 |
2022-12-31 | $1.3M | 32k | 40.22 |
2022-09-30 | $986k | 31k | 32.14 |
2022-06-30 | $896k | 30k | 29.67 |
2022-03-31 | $728k | 26k | 28.09 |
2021-12-31 | $1.1M | 25k | 46.09 |
2021-09-30 | $1.0M | 31k | 32.83 |
2021-06-30 | $1.2M | 34k | 35.04 |
2021-03-31 | $1.3M | 35k | 36.15 |
2020-12-31 | $978k | 34k | 29.04 |
2020-09-30 | $859k | 30k | 28.22 |
2020-06-30 | $1.0M | 32k | 32.33 |
2020-03-31 | $1.3M | 32k | 40.73 |
2019-12-31 | $1.9M | 31k | 61.67 |
2019-09-30 | $2.1M | 29k | 72.87 |
2019-06-30 | $2.2M | 27k | 82.21 |
2019-03-31 | $1.7M | 24k | 70.56 |
2018-12-31 | $1.1M | 24k | 45.03 |
2018-09-30 | $1.2M | 21k | 56.53 |
2018-06-30 | $1.5M | 22k | 66.82 |
2018-03-31 | $1.2M | 21k | 58.24 |
2017-12-31 | $1.3M | 20k | 64.43 |
2017-09-30 | $891k | 17k | 52.47 |
2017-06-30 | $748k | 16k | 46.77 |
2017-03-31 | $796k | 16k | 49.52 |
2016-12-31 | $749k | 12k | 60.66 |
2016-09-30 | $734k | 11k | 66.37 |
2016-06-30 | $563k | 10k | 55.85 |
2016-03-31 | $333k | 9.9k | 33.68 |
2015-12-31 | $442k | 9.8k | 45.17 |
2015-09-30 | $360k | 9.1k | 39.49 |
2015-06-30 | $553k | 8.9k | 62.00 |
2015-03-31 | $557k | 8.9k | 62.51 |
2014-12-31 | $378k | 6.7k | 56.33 |